Fig.1From: Brain pharmacokinetics of two BBB penetrating bispecific antibodies of different sizea Bispecific fusion antibody mAb3D6-scFv8D3 (210 kDa) and di-scFv3D6-8D3 (58 kDa). b Schematic illustration of transferrin-receptor mediated transcytosis at the blood–brain barrier of a bispecfic antibodyBack to article page